Tandem Diabetes Care (TD5A) Financial Statements
Tandem Diabetes Care Financial Overview
Tandem Diabetes Care's market cap is currently $1.19B. The company's EPS TTM is $-0.93; its P/E ratio is -20.58; Tandem Diabetes Care is scheduled to report earnings on November 5, 2026, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.01B | $ 940.20M | $ 747.72M | $ 801.22M | $ 702.80M |
| Gross Profit | $ 530.85M | $ 489.57M | $ 367.69M | $ 412.99M | $ 376.21M |
| Operating Income | $ -78.12M | $ -99.13M | $ -233.23M | $ -92.85M | $ 22.65M |
| EBITDA | $ -174.70M | $ -82.68M | $ -196.46M | $ -74.21M | $ 34.06M |
| Net Income | $ -204.71M | $ -96.03M | $ -222.61M | $ -94.59M | $ 15.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 292.67M | $ 438.33M | $ 467.91M | $ 616.90M | $ 623.81M |
| Total Assets | $ 881.11M | $ 967.66M | $ 952.66M | $ 1.05B | $ 905.14M |
| Total Debt | $ 444.48M | $ 473.56M | $ 415.67M | $ 419.88M | $ 314.67M |
| Net Debt | $ 353.84M | $ 404.33M | $ 356.80M | $ 247.36M | $ 243.49M |
| Total Liabilities | $ 725.94M | $ 704.56M | $ 639.03M | $ 612.84M | $ 472.02M |
| Stockholders' Equity | $ 155.17M | $ 263.10M | $ 313.63M | $ 439.95M | $ 433.11M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.67M | $ 4.99M | $ -58.61M | $ 16.37M | $ 87.85M |
| Operating Cash Flow | $ -9.72M | $ 24.23M | $ -31.81M | $ 50.46M | $ 111.36M |
| Investing Cash Flow | $ 72.88M | $ -23.48M | $ -85.74M | $ 33.17M | $ -186.88M |
| Financing Cash Flow | $ -43.37M | $ 8.37M | $ 4.11M | $ 16.88M | $ 51.93M |
Currency in USD